| La Roche-Posay | 82.7 | 3 | 4 |
| Shopify | 60.0 | 6 | 0 |
| Aveeno | 51.1 | 2 | 1 |
| CNN.com | 49.6 | 4 | 0 |
| No7 product line | 48.7 | 1 | 2 |
| Rolling Stone | 42.7 | 3 | 0 |
| Aesop | 38.6 | 1 | 1 |
| Cetaphil | 38.6 | 1 | 1 |
| KORA Organics | 38.6 | 1 | 1 |
| CeraVe | 38.6 | 1 | 1 |
| Dr. Jart+ | 38.6 | 1 | 1 |
| The Ordinary | 38.6 | 1 | 1 |
| Jaxon Lane | 38.6 | 1 | 1 |
| cleanser | 34.5 | 0 | 3 |
| Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study | 34.5 | 0 | 3 |
| To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin | 34.5 | 0 | 3 |
| An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream | 34.5 | 0 | 3 |
| Today | 33.9 | 2 | 0 |
| Vogue | 33.9 | 2 | 0 |
| Men's Health | 33.9 | 2 | 0 |
| Esquire | 33.9 | 2 | 0 |
| Marie Claire | 33.9 | 2 | 0 |
| Target Corporation | 33.9 | 2 | 0 |
| Neutrogena | 33.9 | 2 | 0 |
| Sara Sidner | 33.9 | 2 | 0 |
| Crossfire | 33.9 | 2 | 0 |
| Fareed Zakaria GPS | 33.9 | 2 | 0 |
| Reliable Sources | 33.9 | 2 | 0 |
| Weekend Today | 33.9 | 2 | 0 |
| Man's World | 33.9 | 2 | 0 |
| The Sixties | 33.9 | 2 | 0 |
| CNNGo | 33.9 | 2 | 0 |
| United Shades of America | 33.9 | 2 | 0 |
| Forbes 30 Under 30 | 33.9 | 2 | 0 |
| Megyn Kelly Today | 33.9 | 2 | 0 |
| Chasing Life | 33.9 | 2 | 0 |
| Branwen R Drew | 33.9 | 2 | 0 |
| Forbes ASAP | 33.9 | 2 | 0 |
| Forbes Best-In-State Wealth Advisor | 33.9 | 2 | 0 |
| Forbes Top 250 Wealth Advisor | 33.9 | 2 | 0 |
| Narad Bastola | 33.9 | 2 | 0 |
| Trend Hunter | 33.9 | 2 | 0 |
| Lab Series | 33.9 | 2 | 0 |
| The Role of Skin Care as an Integral Component in the Management of Acne Vulgaris: Part 2: Tolerability and Performance of a Designated Skin Care Regimen Using a Foam Wash and Moisturizer SPF 30 in Patients with Acne Vulgaris Undergoing Active Treat | 27.3 | 0 | 2 |
| Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability | 27.3 | 0 | 2 |
| Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea | 27.3 | 0 | 2 |
| The Use of Lipohydroxy Acid in Skin Care and Acne Treatment | 27.3 | 0 | 2 |
| Tolerability of a Skin Care Regimen Formulated for Acne‐Prone Skin in Children | 27.3 | 0 | 2 |
| Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care | 27.3 | 0 | 2 |
| Skin care products can aggravate epidermal function: studies in a murine model suggest a pathogenic role in sensitive skin. | 27.3 | 0 | 2 |
| Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment | 27.3 | 0 | 2 |
| Regarding 'Frontal fibrosing alopecia: possible association with leave-on facial skincare products and sunscreens; a questionnaire study'. | 27.3 | 0 | 2 |
| Quality of life in postmenopausal women: translation and validation of MSkinQOL questionnaire to measure the effect of a skincare product in USA | 27.3 | 0 | 2 |
| Tolerance of fragranced and fragrance-free facial cleansers in adults with clinically sensitive skin | 27.3 | 0 | 2 |
| Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin | 27.3 | 0 | 2 |
| Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin. | 27.3 | 0 | 2 |
| Use of formulations for sensitive skin improves the visible signs of aging, including wrinkle size and elasticity. | 27.3 | 0 | 2 |
| Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30 | 27.3 | 0 | 2 |
| A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris | 27.3 | 0 | 2 |
| Adjunctive use of a facial moisturizer SPF 30 containing ceramide precursor improves tolerability of topical tretinoin 0.05%: a randomized, investigator-blinded, split-face study | 27.3 | 0 | 2 |
| Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males | 27.3 | 0 | 2 |
| The Spectrum of Sensitive Skin: Considerations for Skin Care in Vulnerable Populations | 27.3 | 0 | 2 |
| Clinical evidences of benefits from an advanced skin care routine in comparison with a simple routine | 27.3 | 0 | 2 |
| The application of skin care product in acne treatment | 27.3 | 0 | 2 |
| A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. | 27.3 | 0 | 2 |
| WATER'S EDGE DERMATOLOGY | 27.3 | 0 | 2 |
| Influence of Brand Ambassador, Brand Awareness, and Price on Brand Image and Purchasing Decision in Halal Skincare Product (Study on MS Glow Skincare Products in Surabaya) | 27.3 | 0 | 2 |
| Akita | 27.3 | 0 | 2 |
| DabiDabi | 27.3 | 0 | 2 |
| Gum’Ora | 27.3 | 0 | 2 |
| SENSITIVE SKIN, LLC | 27.3 | 0 | 2 |
| PowerV | 27.3 | 0 | 2 |
| CNN | 21.4 | 1 | 0 |
| Urban Decay | 21.4 | 1 | 0 |
| Jenna Bush Hager | 21.4 | 1 | 0 |
| The Wall Street Journal | 21.4 | 1 | 0 |
| Nordstrom | 21.4 | 1 | 0 |
| QVC | 21.4 | 1 | 0 |
| The World's Billionaires | 21.4 | 1 | 0 |
| Braun | 21.4 | 1 | 0 |
| Forbes | 21.4 | 1 | 0 |
| The World's Most Powerful People | 21.4 | 1 | 0 |
| Connect the World | 21.4 | 1 | 0 |
| Forbes Global 2000 | 21.4 | 1 | 0 |
| The Daily Beast | 21.4 | 1 | 0 |
| Eucerin | 21.4 | 1 | 0 |
| Mike Lazaridis | 21.4 | 1 | 0 |
| Larry King Live | 21.4 | 1 | 0 |
| The Salt Lake Tribune | 21.4 | 1 | 0 |
| CVS Pharmacy | 21.4 | 1 | 0 |
| Vichy | 21.4 | 1 | 0 |
| Sephora | 21.4 | 1 | 0 |
| Forbes 400 | 21.4 | 1 | 0 |
| Clinique Laboratories, LLC | 21.4 | 1 | 0 |
| American Morning | 21.4 | 1 | 0 |
| Another Magazine | 21.4 | 1 | 0 |
| Asiaweek | 21.4 | 1 | 0 |
| Candy Crowley | 21.4 | 1 | 0 |
| Mitsubishi Chemical Holdings | 21.4 | 1 | 0 |
| Kiehl's | 21.4 | 1 | 0 |
| Kiko Milano | 21.4 | 1 | 0 |
| Kyra Phillips | 21.4 | 1 | 0 |
| Aveda | 21.4 | 1 | 0 |
| Bluemercury | 21.4 | 1 | 0 |
| Boots Opticians | 21.4 | 1 | 0 |
| CNN Freedom Project | 21.4 | 1 | 0 |
| CNN Airport Network | 21.4 | 1 | 0 |
| CNN Pipeline | 21.4 | 1 | 0 |
| DailyMed | 21.4 | 1 | 0 |
| Dollar Shave Club | 21.4 | 1 | 0 |
| Dr. Hauschka | 21.4 | 1 | 0 |
| Early Start | 21.4 | 1 | 0 |
| Esquire UK | 21.4 | 1 | 0 |
| Boots | 21.4 | 1 | 0 |
| Medical News Today | 21.4 | 1 | 0 |
| OpinionJournal.com | 21.4 | 1 | 0 |
| RazorUSA | 21.4 | 1 | 0 |
| Razor | 21.4 | 1 | 0 |
| Simple | 21.4 | 1 | 0 |
| SkinCeuticals | 21.4 | 1 | 0 |
| Times Now | 21.4 | 1 | 0 |
| Ulta Beauty | 21.4 | 1 | 0 |
| Yahoo! Shopping | 21.4 | 1 | 0 |
| Caudalie | 21.4 | 1 | 0 |
| MALIN+GOETZ | 21.4 | 1 | 0 |
| Forbes' list of the world's highest-paid athletes | 21.4 | 1 | 0 |
| Q11360653 | 21.4 | 1 | 0 |
| CNN Newsroom | 21.4 | 1 | 0 |
| Anthony Bourdain: Parts Unknown | 21.4 | 1 | 0 |
| CNN Films | 21.4 | 1 | 0 |
| State of the Union | 21.4 | 1 | 0 |
| Mohamed Mansour | 21.4 | 1 | 0 |
| Medium | 21.4 | 1 | 0 |
| simplehuman | 21.4 | 1 | 0 |
| PitchBook Data | 21.4 | 1 | 0 |
| Who, What, Wear | 21.4 | 1 | 0 |
| The Colby Echo | 21.4 | 1 | 0 |
| Healthline | 21.4 | 1 | 0 |
| CNN Tonight | 21.4 | 1 | 0 |
| Dermalogica Inc. | 21.4 | 1 | 0 |
| Physics arXiv Blog | 21.4 | 1 | 0 |
| Somebody's Gotta Do It | 21.4 | 1 | 0 |
| This is Life with Lisa Ling | 21.4 | 1 | 0 |
| The Seventies | 21.4 | 1 | 0 |
| Dermstore | 21.4 | 1 | 0 |
| Morgan Spurlock Inside Man | 21.4 | 1 | 0 |
| Harry's | 21.4 | 1 | 0 |
| The Eighties | 21.4 | 1 | 0 |
| Forbes | 21.4 | 1 | 0 |
| Declassified | 21.4 | 1 | 0 |
| Kaitlan Collins | 21.4 | 1 | 0 |
| Byredo | 21.4 | 1 | 0 |
| High Profits | 21.4 | 1 | 0 |
| Marie Claire | 21.4 | 1 | 0 |
| calculator | 17.2 | 0 | 1 |
| solar inverter | 17.2 | 0 | 1 |
| shaving brush | 17.2 | 0 | 1 |
| Facelift | 17.2 | 0 | 1 |
| Clearasil | 17.2 | 0 | 1 |
| triclosan | 17.2 | 0 | 1 |
| shaving cream | 17.2 | 0 | 1 |
| life extension | 17.2 | 0 | 1 |
| fingering | 17.2 | 0 | 1 |
| United States Census Bureau | 17.2 | 0 | 1 |
| Q747793 | 17.2 | 0 | 1 |
| LyX | 17.2 | 0 | 1 |
| toner | 17.2 | 0 | 1 |
| personal lubricant | 17.2 | 0 | 1 |
| user guide | 17.2 | 0 | 1 |
| Donald Davies | 17.2 | 0 | 1 |
| skin care | 17.2 | 0 | 1 |
| handbook | 17.2 | 0 | 1 |
| reticle | 17.2 | 0 | 1 |
| Revlon | 17.2 | 0 | 1 |
| Trisquel | 17.2 | 0 | 1 |
| hugo drink | 17.2 | 0 | 1 |
| Pomodoro Technique | 17.2 | 0 | 1 |
| Biotherm | 17.2 | 0 | 1 |
| kangaroo care | 17.2 | 0 | 1 |
| Artistry | 17.2 | 0 | 1 |
| GDevelop | 17.2 | 0 | 1 |
| How to Use Sexy | 17.2 | 0 | 1 |
| NARS Cosmetics | 17.2 | 0 | 1 |
| Help:Pictures | 17.2 | 0 | 1 |
| Missha | 17.2 | 0 | 1 |
| Alchimie Forever | 17.2 | 0 | 1 |
| Aquaphor | 17.2 | 0 | 1 |
| Bayankala | 17.2 | 0 | 1 |
| Bronner Bros. | 17.2 | 0 | 1 |
| Burma-Shave | 17.2 | 0 | 1 |
| Clarisonic | 17.2 | 0 | 1 |
| clinical prediction rule | 17.2 | 0 | 1 |
| Comedone extraction | 17.2 | 0 | 1 |
| anti-aging cream | 17.2 | 0 | 1 |
| Eight Easy Steps | 17.2 | 0 | 1 |
| Ella Baché | 17.2 | 0 | 1 |
| face cream | 17.2 | 0 | 1 |
| Ernest L. Ransome | 17.2 | 0 | 1 |
| Freederm | 17.2 | 0 | 1 |
| Gold Bond | 17.2 | 0 | 1 |
| How to Get Everything You Ever Wanted in Ten Easy Steps | 17.2 | 0 | 1 |
| satin glass | 17.2 | 0 | 1 |
| Natural skin care | 17.2 | 0 | 1 |
| Razor Burn | 17.2 | 0 | 1 |
| Rise shaving cream | 17.2 | 0 | 1 |
| Sensitive Skin | 17.2 | 0 | 1 |
| Sensitive Skin Magazine | 17.2 | 0 | 1 |
| Sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin type | 17.2 | 0 | 1 |
| Category:Skin care | 17.2 | 0 | 1 |
| Shaving Cream | 17.2 | 0 | 1 |
| Simple Skincare | 17.2 | 0 | 1 |
| The Millennial Project | 17.2 | 0 | 1 |
| The Pad and How to Use It | 17.2 | 0 | 1 |
| Weapons system trainer | 17.2 | 0 | 1 |
| Category:External signs of ageing | 17.2 | 0 | 1 |
| Cat-a-lot | 17.2 | 0 | 1 |
| Category:Shaving cream brands | 17.2 | 0 | 1 |
| OXY | 17.2 | 0 | 1 |
| razor burn | 17.2 | 0 | 1 |
| Hada Labo | 17.2 | 0 | 1 |
| Cidesco | 17.2 | 0 | 1 |
| baby oil | 17.2 | 0 | 1 |
| conflation | 17.2 | 0 | 1 |
| Wikivoyage:How to use dynamic maps | 17.2 | 0 | 1 |
| Help:DjVu files | 17.2 | 0 | 1 |
| Pechoin | 17.2 | 0 | 1 |
| How to Use Guys with Secret Tips | 17.2 | 0 | 1 |
| Face Cream | 17.2 | 0 | 1 |
| Premier Dead Sea | 17.2 | 0 | 1 |
| Nardo's Natural | 17.2 | 0 | 1 |
| Rachel K | 17.2 | 0 | 1 |
| Sensitive Skin | 17.2 | 0 | 1 |
| library instruction | 17.2 | 0 | 1 |
| Q17478340 | 17.2 | 0 | 1 |
| Johnson's Baby | 17.2 | 0 | 1 |
| Reactor | 17.2 | 0 | 1 |
| Morning Routine | 17.2 | 0 | 1 |
| How to Use Your Mind | 17.2 | 0 | 1 |
| My Beauty Diary | 17.2 | 0 | 1 |
| Zoe Foster Blake | 17.2 | 0 | 1 |
| ATRIAS 2.1 Handbook/General Information/How to use this WikiBooks | 17.2 | 0 | 1 |
| A First Course to Network Coding/How to Use this Book | 17.2 | 0 | 1 |
| Typical Morning Routine | 17.2 | 0 | 1 |
| Skin care | 17.2 | 0 | 1 |
| Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging | 17.2 | 0 | 1 |
| Blueprint for Revolution | 17.2 | 0 | 1 |
| Joe Smith: How to use a paper towel | 17.2 | 0 | 1 |
| Noreena Hertz: How to use experts -- and when not to | 17.2 | 0 | 1 |
| Sebastian Wernicke: How to use data to make a hit TV show | 17.2 | 0 | 1 |
| Apache NiFi | 17.2 | 0 | 1 |
| Aveeno Baby product line | 17.2 | 0 | 1 |
| EOS Products, LLC | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Chlorhexidine skin care for the prevention of infection in term neonates | 17.2 | 0 | 1 |
| Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia | 17.2 | 0 | 1 |
| Dietary selenium protects against selected signs of aging and methylmercury exposure | 17.2 | 0 | 1 |
| Population-Based Inorganic Mercury Biomonitoring and the Identification of Skin Care Products as a Source of Exposure in New York City | 17.2 | 0 | 1 |
| How to use the world's scarce selenium resources efficiently to increase the selenium concentration in food | 17.2 | 0 | 1 |
| Tropic Skin Care | 17.2 | 0 | 1 |
| How to Make a Mother in Five Easy Steps | 17.2 | 0 | 1 |
| Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study | 17.2 | 0 | 1 |
| How to use light and dark to adapt to shiftwork | 17.2 | 0 | 1 |
| Athena Teaches the Young Man How to Use a Weapon | 17.2 | 0 | 1 |
| Crewstation analysis programs - an easy to use personal computer-based lighting and visibility analysis software package for underground mining equipment | 17.2 | 0 | 1 |
| How to Use Workers' Compensation Data to Identify High-Risk Groups | 17.2 | 0 | 1 |
| Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy | 17.2 | 0 | 1 |
| How to use CT texture analysis for prognostication of non-small cell lung cancer | 17.2 | 0 | 1 |
| Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients | 17.2 | 0 | 1 |
| Targeted Treatment in Childhood Epilepsy Syndromes | 17.2 | 0 | 1 |
| How to use the nominal group and Delphi techniques | 17.2 | 0 | 1 |
| The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive? | 17.2 | 0 | 1 |
| How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease | 17.2 | 0 | 1 |
| How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer | 17.2 | 0 | 1 |
| Skin care: Historical and contemporary views | 17.2 | 0 | 1 |
| How to use fMRI functional localizers to improve EEG/MEG source estimation | 17.2 | 0 | 1 |
| Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques | 17.2 | 0 | 1 |
| Bone-targeted treatment in prostate cancer | 17.2 | 0 | 1 |
| Fragile X Syndrome and Targeted Treatment Trials | 17.2 | 0 | 1 |
| Bruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomas | 17.2 | 0 | 1 |
| The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection | 17.2 | 0 | 1 |
| Drug Reaction, Skin Care, Skin Loss | 17.2 | 0 | 1 |
| How to use outcomes questionnaires: pearls and pitfalls | 17.2 | 0 | 1 |
| Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles | 17.2 | 0 | 1 |
| Tau-targeted treatment strategies in Alzheimer's disease | 17.2 | 0 | 1 |
| Managing age-related hearing loss: how to use hearing aids efficiently - a mini-review | 17.2 | 0 | 1 |
| Improving adherence to acne treatment: the emerging role of application software | 17.2 | 0 | 1 |
| Image Statistics and the Fine Lines of Material Perception | 17.2 | 0 | 1 |
| Antibiotic resistance in acne treatment | 17.2 | 0 | 1 |
| Interventions to increase adherence to acne treatment | 17.2 | 0 | 1 |
| New developments in acne treatment: role of combination adapalene-benzoylperoxide | 17.2 | 0 | 1 |
| Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system | 17.2 | 0 | 1 |
| Dermatology update: The dawn of targeted treatment | 17.2 | 0 | 1 |
| Polymeric nanoparticles for targeted treatment in oncology: current insights | 17.2 | 0 | 1 |
| Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group | 17.2 | 0 | 1 |
| Neonatal skin care: the scientific basis for practice | 17.2 | 0 | 1 |
| Cosmetics and skin care products. A historical perspective | 17.2 | 0 | 1 |
| Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: Part 2: When and how to use various agents | 17.2 | 0 | 1 |
| Skin care management: educational aspects | 17.2 | 0 | 1 |
| Emblica cascading antioxidant: a novel natural skin care ingredient | 17.2 | 0 | 1 |
| Role of vitamins in skin care | 17.2 | 0 | 1 |
| Evidence-Based Skin Care Management in Radiation Therapy: Clinical Update | 17.2 | 0 | 1 |
| Targeted treatment of prostate cancer | 17.2 | 0 | 1 |
| Skin care practices for newborns and infants: review of the clinical evidence for best practices | 17.2 | 0 | 1 |
| Evidence-based skin care management in radiation therapy | 17.2 | 0 | 1 |
| The benefits of implementing a new skin care protocol in nursing homes | 17.2 | 0 | 1 |
| The validity of skin care protocols followed by women with breast cancer receiving external radiation | 17.2 | 0 | 1 |
| Evidence-Based Skin Care: A Systematic Literature Review and the Development of a Basic Skin Care Algorithm | 17.2 | 0 | 1 |
| Skin Care | 17.2 | 0 | 1 |
| Innovations in natural ingredients and their use in skin care | 17.2 | 0 | 1 |
| A review of perineal skin care protocols and skin barrier product use | 17.2 | 0 | 1 |
| How to use capillary refill time | 17.2 | 0 | 1 |
| A survey of skin problems and skin care regimens in the elderly | 17.2 | 0 | 1 |
| Steroid sulfatase activity in epidermis of acne-prone and non-acne-prone skin of patients with acne vulgaris | 17.2 | 0 | 1 |
| Hexachlorophene emulsions and antiseptic skin care of newborn infants | 17.2 | 0 | 1 |
| How to use personal computer based DICOM image display tool: using a binary editor and ImageJ to analyze the format of DICOM image | 17.2 | 0 | 1 |
| MR urography in children. Part 2: how to use ImageJ MR urography processing software | 17.2 | 0 | 1 |
| cementitious foam insulation | 17.2 | 0 | 1 |
| Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics | 17.2 | 0 | 1 |
| Fabrication of optimized oil-water separation devices through the targeted treatment of silica meshes | 17.2 | 0 | 1 |
| Comparative study of normal and sensitive skin aerobic bacterial populations | 17.2 | 0 | 1 |
| Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment | 17.2 | 0 | 1 |
| sway | 17.2 | 0 | 1 |
| A Survey of Skin Problems and Skin Care Regimens in the Elderly | 17.2 | 0 | 1 |
| Bolden | 17.2 | 0 | 1 |
| Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India | 17.2 | 0 | 1 |
| Social medicine assessment after surgical and targeted treatment of renal cell cancer | 17.2 | 0 | 1 |
| How to use unfractionated heparin to treat neonatal thrombosis in clinical practice | 17.2 | 0 | 1 |
| Michigan Center for Skin Care Research | 17.2 | 0 | 1 |
| New York Laser and Skin Care | 17.2 | 0 | 1 |
| Skin Care and Laser Physicians of Beverly Hills | 17.2 | 0 | 1 |
| Institut Esthederm | 17.2 | 0 | 1 |
| Gold Skin Care Center | 17.2 | 0 | 1 |
| Associated Skin Care Specialists | 17.2 | 0 | 1 |
| Perineal skin care for the incontinent patient | 17.2 | 0 | 1 |
| Tender mercies: providing skin care for an incontinent patient | 17.2 | 0 | 1 |
| Protecting perineal skin integrity. Incontinent patients present unique challenges to successful skin care management. | 17.2 | 0 | 1 |
| Working with respiratory waveforms: how to use bedside graphics | 17.2 | 0 | 1 |
| E45 cream | 17.2 | 0 | 1 |
| Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer | 17.2 | 0 | 1 |
| Postmodernism for healthcare workers in 13 easy steps | 17.2 | 0 | 1 |
| Incorporating skin care into a facial plastic surgery practice | 17.2 | 0 | 1 |
| How to use composite indicator and linear programming model for determine sustainable tourism | 17.2 | 0 | 1 |
| Phototheranostic Porphyrin Nanoparticles Enable Visualization and Targeted Treatment of Head and Neck Cancer in Clinically Relevant Models. | 17.2 | 0 | 1 |
| How to use continuous quality improvement theory and statistical quality control tools in a multispecialty clinic | 17.2 | 0 | 1 |
| The Five Myths of MMN: Redefining How to Use MMN in Basic and Clinical Research | 17.2 | 0 | 1 |
| Easy to use plastic optical fiber-based biosensor for detection of butanal | 17.2 | 0 | 1 |
| Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation | 17.2 | 0 | 1 |
| Daily consumption of the collagen supplement Pure Gold Collagen® reduces visible signs of aging | 17.2 | 0 | 1 |
| Evidence-based urology in practice: how to use PubMed effectively | 17.2 | 0 | 1 |
| Photodynamic therapy for unresectable cholangiocarcinoma: contribution of single operator cholangioscopy for targeted treatment | 17.2 | 0 | 1 |
| Fluoroquinolones: how to use (but not overuse) these antibiotics | 17.2 | 0 | 1 |
| Prediction models and development of an easy to use open-access tool for measuring lung function of individuals with motor complete spinal cord injury | 17.2 | 0 | 1 |
| RatLab: an easy to use tool for place code simulations | 17.2 | 0 | 1 |
| AGANTG: a Microsoft EXCEL 5.0-visual basic routine for the analysis of dose-response data | 17.2 | 0 | 1 |
| Advanced statistical techniques: how to use your data more effectively? | 17.2 | 0 | 1 |
| How to use reports to gather data for better management. | 17.2 | 0 | 1 |
| How to use malpractice data in quality assessment | 17.2 | 0 | 1 |
| Baxter shows hospitals how to use cost data to prepare for price competition | 17.2 | 0 | 1 |
| How to use a computerized data base for ward management | 17.2 | 0 | 1 |
| Getting the appropriate set of sequences for your research: how to use sequence retrieval system on DNA Data Bank of Japan (DDBJ) | 17.2 | 0 | 1 |
| Improving data collection in four easy steps. | 17.2 | 0 | 1 |
| Evidence-based dentistry: Part II. Searching for answers to clinical questions: how to use MEDLINE. | 17.2 | 0 | 1 |
| How to use published complete case results from weight loss studies in a missing data sensitivity analysis | 17.2 | 0 | 1 |
| How to use the medical library as a clinical tool | 17.2 | 0 | 1 |
| Using OASIS data to improve skin care | 17.2 | 0 | 1 |
| How to use financial data as a basic program planning tool; a program director's guide | 17.2 | 0 | 1 |
| Technique review: how to use RNA interference | 17.2 | 0 | 1 |
| Professional writing. A collective experience. Archives, how to use them | 17.2 | 0 | 1 |
| Develop a data and device destruction policy in five easy steps | 17.2 | 0 | 1 |
| How to use scheduling data to improve efficiency. | 17.2 | 0 | 1 |
| RUMINANT NUTRITION SYMPOSIUM: How to use data on the rumen microbiome to improve our understanding of ruminant nutrition | 17.2 | 0 | 1 |
| How to use factual data to plan wisely. | 17.2 | 0 | 1 |
| Exposure data for cosmetic products: lipstick, body lotion, and face cream | 17.2 | 0 | 1 |
| How to use molecular marker data to measure evolutionary parameters in wild populations | 17.2 | 0 | 1 |
| A knowledge audit of the managers of primary care organizations: top priority is how to use routinely collected clinical data for quality improvement | 17.2 | 0 | 1 |
| How to Use Relational Databases. DATA RETRIEVAL WITH STRUCTURED QUERY LANGUAGE | 17.2 | 0 | 1 |
| How to use data analytics to engage physicians | 17.2 | 0 | 1 |
| Skin care products and subtle data manipulation | 17.2 | 0 | 1 |
| Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling | 17.2 | 0 | 1 |
| Selective photothermolysis of the sebaceous glands for acne treatment | 17.2 | 0 | 1 |
| Research in physical medicine and rehabilitation. III. The chart review or how to use clinical data for exploratory retrospective studies. | 17.2 | 0 | 1 |
| Harnessing Data for Real Improvements. Three projects demonstrate how to use data to improve patient care in EMS systems | 17.2 | 0 | 1 |
| Exposure data for cosmetic products: facial cleanser, hair conditioner, and eye shadow | 17.2 | 0 | 1 |
| A systematic review of randomised controlled trials evaluating the effect of mother/baby skin-to-skin care on successful breast feeding | 17.2 | 0 | 1 |
| Improving skin care through data: a pitch for patient safety incident reporting. | 17.2 | 0 | 1 |
| B-cell-targeted treatment for multiple sclerosis: mechanism of action and clinical data | 17.2 | 0 | 1 |
| Correlation between percutaneous penetration of methyl nicotinate and sensitive skin, using laser Doppler imaging | 17.2 | 0 | 1 |
| Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia | 17.2 | 0 | 1 |
| Preoperative and postoperative skin care with laser resurfacing | 17.2 | 0 | 1 |
| 'Tweaked' GammaPlan for target volume measurement in non-fiducial based images: a simple routine for follow-up assessment | 17.2 | 0 | 1 |
| Guidelines for the management of squamous cell carcinoma in organ transplant recipients | 17.2 | 0 | 1 |
| How to use the Doppler velocimetry for the screening of fetal welfare in pre-parturient period | 17.2 | 0 | 1 |
| High resolution anoscopy and targeted treatment of high-grade squamous intraepithelial lesions | 17.2 | 0 | 1 |
| A systematic review of topical skin care in aged care facilities. | 17.2 | 0 | 1 |
| Interstitial photodynamic therapy for a symptom-targeted treatment of complex vascular malformations in the head and neck region | 17.2 | 0 | 1 |
| Skin care for men and its marketing | 17.2 | 0 | 1 |
| A randomised clinical trial of subgrouping and targeted treatment for low back pain compared with best current care. The STarT Back Trial Study Protocol. | 17.2 | 0 | 1 |
| Quantitative rRNA-targeted solution-based hybridization assay using peptide nucleic acid molecular beacons | 17.2 | 0 | 1 |
| The rough guide to in silico function prediction, or how to use sequence and structure information to predict protein function | 17.2 | 0 | 1 |
| Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data | 17.2 | 0 | 1 |
| Comparison of clinical efficacies of sodium ascorbyl phosphate, retinol and their combination in acne treatment | 17.2 | 0 | 1 |
| Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti–HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia | 17.2 | 0 | 1 |
| Valve-in-valve apps: why and how they were developed and how to use them | 17.2 | 0 | 1 |
| Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study | 17.2 | 0 | 1 |
| Skin to skin care in the neonatal intensive care unit: more data regarding seriously ill infants are badly needed. Commentary on Heimann et al.: Impact of skin to skin care, prone and supine positioning on cardiorespiratory parameters and thermoregu | 17.2 | 0 | 1 |
| A controlled multi-center study evaluating the efficacy of Vivité skin care in the treatment of photoaging of the face, eye and mouth. | 17.2 | 0 | 1 |
| Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome | 17.2 | 0 | 1 |
| Why and how to use office spirometry. | 17.2 | 0 | 1 |
| Today's strategies for treating postoperative hypertension. Immediate evaluation and targeted treatment are required. | 17.2 | 0 | 1 |
| Objective assessment of intensive targeted treatment for solar lentigines using intense pulsed light with wavelengths between 500 and 635 nm | 17.2 | 0 | 1 |
| Hormonal antiandrogens in acne treatment | 17.2 | 0 | 1 |
| Managing utilization successfully in 12 not-so-easy steps | 17.2 | 0 | 1 |
| How to use the computing environment R to analyze ATP-induced ribonucleotide reductase R1 hexamerization data | 17.2 | 0 | 1 |
| Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy | 17.2 | 0 | 1 |
| Acute encephalitis in intensive care unit: how to use pulses of methylprednisolone | 17.2 | 0 | 1 |
| Skin care of the pediatric patient | 17.2 | 0 | 1 |
| SATB1-mediated functional packaging of chromatin into loops | 17.2 | 0 | 1 |
| Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group | 17.2 | 0 | 1 |
| How to use light and dark to produce circadian adaptation to night shift work | 17.2 | 0 | 1 |
| How to use cerebral vasodilators and metabolic activators | 17.2 | 0 | 1 |
| Neonatal skin care: the scientific basis for practice. | 17.2 | 0 | 1 |
| How to use Pubmed for beginners | 17.2 | 0 | 1 |
| IMPaCT Back study protocol. Implementation of subgrouping for targeted treatment systems for low back pain patients in primary care: a prospective population-based sequential comparison | 17.2 | 0 | 1 |
| "Traditional" medical therapy for unstable angina. How important? How to use? | 17.2 | 0 | 1 |
| How to use libraries and modern information sources | 17.2 | 0 | 1 |
| How to use the results of an economic evaluation | 17.2 | 0 | 1 |
| How to use ACE-inhibitors, beta-blockers, and newer therapies in AMI. | 17.2 | 0 | 1 |
| Cosmetics, skin care, and appearance in teenagers | 17.2 | 0 | 1 |
| Assessing diagnostic and screening tests: Part 2. How to use the research literature on diagnosis | 17.2 | 0 | 1 |
| How to use contextual knowledge in medical case-based reasoning systems: a survey on very recent trends | 17.2 | 0 | 1 |
| How to Use the Specific Formula of Heredity | 17.2 | 0 | 1 |
| How to use articles about diagnostic technology: gastric tonometry | 17.2 | 0 | 1 |
| How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure | 17.2 | 0 | 1 |
| Skin care in old age. | 17.2 | 0 | 1 |
| 0.5% Liposome-encapsulated 5-aminolevulinic acid (ALA) photodynamic therapy for acne treatment. | 17.2 | 0 | 1 |
| Vestibular dysfunction: prevalence, impact and need for targeted treatment | 17.2 | 0 | 1 |
| Asthma medications and how to use them | 17.2 | 0 | 1 |
| How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis | 17.2 | 0 | 1 |
| Evaluation of a novel very high sun-protection-factor moisturizer in adults with rosacea-prone sensitive skin | 17.2 | 0 | 1 |
| Sensible use of antisense: how to use oligonucleotides as research tools | 17.2 | 0 | 1 |
| Therapeutic agents and herbs in topical application for acne treatment | 17.2 | 0 | 1 |
| Treatment of inflammatory bowel disease with azathioprine: how to use it in 1999. | 17.2 | 0 | 1 |
| Current state of acne treatment: highlighting lasers, photodynamic therapy, and chemical peels | 17.2 | 0 | 1 |
| Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence-Based Medicine Working Group | 17.2 | 0 | 1 |
| Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: the Northwestern University experience. | 17.2 | 0 | 1 |
| Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case-control study | 17.2 | 0 | 1 |
| Patient hygiene: Part 2. Skin care. Keeping the outside healthy. | 17.2 | 0 | 1 |
| Targeted treatment of chronic myeloid leukemia: role of imatinib. | 17.2 | 0 | 1 |
| Sensitive Skin: Assessment of the Skin Barrier Using Confocal Raman Microspectroscopy. | 17.2 | 0 | 1 |
| Effectiveness of topical skin care provided in aged care facilities | 17.2 | 0 | 1 |
| When and how to use adhesive film dressings | 17.2 | 0 | 1 |
| When and how to use hydrocolloid dressings. | 17.2 | 0 | 1 |
| Water-structuring technology with the molecular chaperone proteins: indicated application of the α-crystallin domains and imidazole-containing peptidomimetics in cosmetic skin care systems or dermatological therapeutic drug carrier formulations | 17.2 | 0 | 1 |
| Should acyclovir prophylaxis be used in late pregnancy in women with recurrent genital herpes infection? How to use a clinical decision analysis | 17.2 | 0 | 1 |
| Neonatal skin care: clinical outcomes of the AWHONN/NANN evidence-based clinical practice guideline. Association of Women's Health, Obstetric and Neonatal Nurses and the National Association of Neonatal Nurses | 17.2 | 0 | 1 |
| Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation. | 17.2 | 0 | 1 |
| Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa | 17.2 | 0 | 1 |
| Treating the patient with multiple cosmetic product allergies. A problem-oriented approach to sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin in the American population: prevalence, clinical data, and role of the dermatologist | 17.2 | 0 | 1 |
| Protective Skin Care Behaviors in Cancer Survivors | 17.2 | 0 | 1 |
| Neonatal skin care | 17.2 | 0 | 1 |
| Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. | 17.2 | 0 | 1 |
| A simple intervention to reinforce awareness of tanning bed use and skin cancer in non‐medical skin care professionals in Southern California | 17.2 | 0 | 1 |
| Advances in interleukin 2 receptor targeted treatment | 17.2 | 0 | 1 |
| Sebum, cosmetics, and skin care | 17.2 | 0 | 1 |
| Using a Hydroquinone/Tretinoin-based Skin Care System Before and After Electrodesiccation and Curettage of Superficial Truncal Basal Cell Carcinoma: A Multicenter, Randomized, Investigator-blind, Controlled Study of Short-term Healing | 17.2 | 0 | 1 |
| Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed | 17.2 | 0 | 1 |
| The effect of walking on falls in older people: the 'Easy Steps to Health' randomized controlled trial study protocol. | 17.2 | 0 | 1 |
| Newborn umbilical cord and skin care in Sylhet District, Bangladesh: implications for the promotion of umbilical cord cleansing with topical chlorhexidine | 17.2 | 0 | 1 |
| The use of Clinisan in the skin care of the incontinent patient | 17.2 | 0 | 1 |
| Effect of standardized skin care regimens on neonatal skin barrier function in different body areas | 17.2 | 0 | 1 |
| Analyzing Continuous Measures in HIV Prevention Research Using Semiparametric Regression and Parametric Regression Models: How to Use Data to Get the (Right) Answer? | 17.2 | 0 | 1 |
| Skin care for the newborn | 17.2 | 0 | 1 |
| Practical uses of botanicals in skin care | 17.2 | 0 | 1 |
| How to use evidence-based medicine in anaesthesiology | 17.2 | 0 | 1 |
| Skin care for older people with incontinence. | 17.2 | 0 | 1 |
| How to use nerve fiber layer examination in the management of glaucoma | 17.2 | 0 | 1 |
| The latest choice in wound closure. When and how to use Dermabond. | 17.2 | 0 | 1 |
| The quality of skin care products and their ingredients | 17.2 | 0 | 1 |
| The role of ancillary personnel and skin care | 17.2 | 0 | 1 |
| Users' guide to evidence-based surgery: how to use an article evaluating surgical interventions. Evidence-Based Surgery Working Group | 17.2 | 0 | 1 |
| Validation of Eupatorium triplinerve Vahl leaves, a skin care herb from East Kalimantan, using a melanin biosynthesis assay. | 17.2 | 0 | 1 |
| Nutritional skin care: health effects of micronutrients and fatty acids | 17.2 | 0 | 1 |
| Mobile connected dermatoscope and confocal laser scanning microscope: a useful combination applied in facial simple sensitive skin | 17.2 | 0 | 1 |
| Pteros: fast and easy to use open-source C++ library for molecular analysis. | 17.2 | 0 | 1 |
| Immunotherapy for inhalant allergies. Guidelines for why, when, and how to use this treatment | 17.2 | 0 | 1 |
| How to use the IUPHAR receptor database to navigate pharmacological data | 17.2 | 0 | 1 |
| Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care | 17.2 | 0 | 1 |
| Rosacea skin care. | 17.2 | 0 | 1 |
| Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group | 17.2 | 0 | 1 |
| Parental experiences of providing skin-to-skin care to their newborn infant--part 2: a qualitative meta-synthesis | 17.2 | 0 | 1 |
| Parental experiences of providing skin-to-skin care to their newborn infant--part 1: a qualitative systematic review | 17.2 | 0 | 1 |
| Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group | 17.2 | 0 | 1 |
| How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus | 17.2 | 0 | 1 |
| Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group | 17.2 | 0 | 1 |
| When and how to use instrumental variables in palliative care research | 17.2 | 0 | 1 |
| Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group | 17.2 | 0 | 1 |
| Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group | 17.2 | 0 | 1 |
| How to use ECG for decision support in the catheterization laboratory. Cases with ST-segment depression acute coronary syndrome | 17.2 | 0 | 1 |
| How to use ECG for decision support in the catheterization laboratory. Cases with inferior ST elevation myocardial infarction. | 17.2 | 0 | 1 |
| Targeted treatment of advanced and metastaticbreast cancer with lapatinib. | 17.2 | 0 | 1 |
| How to use education as an intervention in osteoarthritis | 17.2 | 0 | 1 |
| Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment? | 17.2 | 0 | 1 |
| How to use near real-time health indicators to support decision-making during a heat wave: the example of the French heat wave warning system | 17.2 | 0 | 1 |
| Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome. | 17.2 | 0 | 1 |
| Atopic Dermatitis: Skin-Directed Management | 17.2 | 0 | 1 |
| New directions in skin care | 17.2 | 0 | 1 |
| Antibiotic resistance: shifting the paradigm in topical acne treatment | 17.2 | 0 | 1 |
| Efficacy of barrier creams in comparison to skin care products in dental laboratory technicians--a controlled trial | 17.2 | 0 | 1 |
| Light-based therapies in acne treatment | 17.2 | 0 | 1 |
| Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors--the first molecular targeted treatment | 17.2 | 0 | 1 |
| Topical antioxidants in radiodermatitis: a clinical review | 17.2 | 0 | 1 |
| Design of a photostabilizer having built-in antioxidant functionality and its utility in obtaining broad-spectrum sunscreen formulations | 17.2 | 0 | 1 |
| Hyperpigmentation: types, diagnostics and targeted treatment options | 17.2 | 0 | 1 |
| Practice of skin protection and skin care among German surgeons and influence on the efficacy of surgical hand disinfection and surgical glove perforation | 17.2 | 0 | 1 |
| Phenolic constituents of Malus doumeri var. formosana in the field of skin care | 17.2 | 0 | 1 |
| Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. | 17.2 | 0 | 1 |
| Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines | 17.2 | 0 | 1 |
| Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. | 17.2 | 0 | 1 |
| How to use nesiritide in treating decompensated heart failure | 17.2 | 0 | 1 |
| How to Use Your Clinical Judgment to Screen for and Diagnose Psychogenic Nonepileptic Seizures without Video Electroencephalogram | 17.2 | 0 | 1 |
| Reducing wrinkles and other signs of aging. | 17.2 | 0 | 1 |
| In vivo and in vitro analysis of low level light therapy: a useful therapeutic approach for sensitive skin | 17.2 | 0 | 1 |
| When and how to use hydrogels | 17.2 | 0 | 1 |
| When and how to use iodine dressings. | 17.2 | 0 | 1 |
| Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies | 17.2 | 0 | 1 |
| Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases | 17.2 | 0 | 1 |
| Affective disorders as potential complication of anti-acne treatment with isotretinoin: A case series | 17.2 | 0 | 1 |
| High consumption of tetracyclines for acne treatment among young Danish adults | 17.2 | 0 | 1 |
| How to use various types of syringes | 17.2 | 0 | 1 |
| Skin care management in cancer patients: an evaluation of quality of life and tolerability | 17.2 | 0 | 1 |
| One more step towards justifying targeted treatment for insomnia | 17.2 | 0 | 1 |
| Metabolic basis for recommending how to use alcohol | 17.2 | 0 | 1 |
| The catheter. How to use and when not to use | 17.2 | 0 | 1 |
| An antiaging skin care system containing alpha hydroxy acids and vitamins improves the biomechanical parameters of facial skin. | 17.2 | 0 | 1 |
| Do-it-yourself guide: how to use the modern single-molecule toolkit | 17.2 | 0 | 1 |
| User's guide to the orthopaedic literature: how to use a systematic literature review | 17.2 | 0 | 1 |
| A Randomized Controlled Trial of Skin Care Protocols for Facial Resurfacing: Lessons Learned from the Plastic Surgery Educational Foundationʼs Skin Products Assessment Research Study | 17.2 | 0 | 1 |
| An overview of skin care and faecal incontinence. | 17.2 | 0 | 1 |
| Gaining the summit: easy steps to attaining ASPAN research grants | 17.2 | 0 | 1 |
| Efficacy, safety, and subject satisfaction of a specified skin care regimen to cleanse, medicate, moisturize, and protect the skin of patients under treatment for acne vulgaris | 17.2 | 0 | 1 |
| Contributing to marine pollution by washing your face: microplastics in facial cleansers | 17.2 | 0 | 1 |
| Long-lasting insecticide-treated house screens and targeted treatment of productive breeding-sites for dengue vector control in Acapulco, Mexico | 17.2 | 0 | 1 |
| Role of inflammation in cardiovascular disease: how to use C-reactive protein in clinical practice | 17.2 | 0 | 1 |
| Mos in the oocyte: how to use MAPK independently of growth factors and transcription to control meiotic divisions | 17.2 | 0 | 1 |
| How to use not-always-reliable binding site information in protein-protein docking prediction | 17.2 | 0 | 1 |
| A new lightening approach to acne treatment-combining therapy modalities for maximizing acne treatment: Phototherapy (LHE™), drugs, skin rejuvenation and skin tightening | 17.2 | 0 | 1 |
| Safety of skin care products during pregnancy | 17.2 | 0 | 1 |
| Insights into the molecular pathogenesis and targeted treatment of lymphedema | 17.2 | 0 | 1 |
| Estrogenic and anti-estrogenic activity of off-the-shelf hair and skin care products | 17.2 | 0 | 1 |
| A Controlled Trial to Determine the Efficacy of Red and Near-Infrared Light Treatment in Patient Satisfaction, Reduction of Fine Lines, Wrinkles, Skin Roughness, and Intradermal Collagen Density Increase | 17.2 | 0 | 1 |
| Update and future of systemic acne treatment | 17.2 | 0 | 1 |
| How to use PSA to screen for prostate cancer. | 17.2 | 0 | 1 |
| Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab | 17.2 | 0 | 1 |
| Optimising the therapeutic trinity of active ingredient, delivery system and functional packaging | 17.2 | 0 | 1 |
| Solar exposure(s) and facial clinical signs of aging in Chinese women: impacts upon age perception | 17.2 | 0 | 1 |
| Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies | 17.2 | 0 | 1 |
| Monoclonal antibody drug immunoconjugates for targeted treatment of cancer | 17.2 | 0 | 1 |
| Photopneumatic technology in acne treatment and skin rejuvenation: histological assessment | 17.2 | 0 | 1 |
| Efficacy and tolerability of a facial serum for fine lines, wrinkles, and photodamaged skin | 17.2 | 0 | 1 |
| Buprenorphine: how to use it right | 17.2 | 0 | 1 |
| How to use nitrates | 17.2 | 0 | 1 |
| Fast Absorbing Gut Suture versus Cyanoacrylate Tissue Adhesive in the Epidermal Closure of Linear Repairs Following Mohs Micrographic Surgery | 17.2 | 0 | 1 |
| Patient education. How to use a condom | 17.2 | 0 | 1 |
| Targeted Treatment of Differentiated and Medullary Thyroid Cancer | 17.2 | 0 | 1 |
| Trends in aging and skin care: Ayurvedic concepts | 17.2 | 0 | 1 |
| Tackling the shortage of donor kidneys: how to use the best that we have | 17.2 | 0 | 1 |
| Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface | 17.2 | 0 | 1 |
| Total turnaround: how to use national benchmarks, an operational review, and focus change strategies to totally turn an agency around. | 17.2 | 0 | 1 |
| Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected S | 17.2 | 0 | 1 |
| Erdheim-Chester disease: from palliative care to targeted treatment | 17.2 | 0 | 1 |
| Response: how to use a window of opportunity | 17.2 | 0 | 1 |
| Interferon treatments: how to use an endogenous system as a therapeutic agent | 17.2 | 0 | 1 |
| Skin care product evaluation in a group of critically ill, premature neonates: a descriptive study. | 17.2 | 0 | 1 |
| The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer | 17.2 | 0 | 1 |
| “Il Corpo Ritrovato”: Dermocosmetological Skin Care Project for the Oncologic Patient | 17.2 | 0 | 1 |
| Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings | 17.2 | 0 | 1 |
| Cardiac enzymes. How to use serial determinations to confirm acute myocardial infarction | 17.2 | 0 | 1 |
| Users' guide to the surgical literature: how to use a systematic literature review and meta-analysis. | 17.2 | 0 | 1 |
| Estrogens and progestins: what to use and how to use it | 17.2 | 0 | 1 |
| Can we predict the prognosis of HIV infection? How to use the findings of a prospective study | 17.2 | 0 | 1 |
| Quality of Life and Targeted Treatment for Metastatic Renal Cell Carcinoma | 17.2 | 0 | 1 |
| Acne treatment patterns, expectations, and satisfaction among adult females of different races/ethnicities | 17.2 | 0 | 1 |
| Biologically targeted treatment of non-small-cell lung cancer: focus on epidermal growth factor receptor | 17.2 | 0 | 1 |
| Targeted treatment for chronic lymphocytic leukemia | 17.2 | 0 | 1 |
| How to use a rotahaler | 17.2 | 0 | 1 |
| Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies | 17.2 | 0 | 1 |
| A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community | 17.2 | 0 | 1 |
| Using the Ottawa Model of Research Use to implement a skin care program | 17.2 | 0 | 1 |
| The economic benefits of increasing kangaroo skin-to-skin care and breastfeeding in neonatal units: analysis of a pragmatic intervention in clinical practice | 17.2 | 0 | 1 |
| How to use statins in patients with chronic liver disease | 17.2 | 0 | 1 |
| Skin-to-Skin Care and the Development of the Preterm Infant Oral Microbiome | 17.2 | 0 | 1 |
| Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate | 17.2 | 0 | 1 |
| Practices of skin care among nurses in medical and surgical intensive care units: results of a self-administered questionnaire | 17.2 | 0 | 1 |
| Development of the facial skin care index: a health-related outcomes index for skin cancer patients | 17.2 | 0 | 1 |
| Appendix II: How to use antibacterial agents in the elderly | 17.2 | 0 | 1 |
| Targeted treatment in primary care for low back pain: the treatment system and clinical training programmes used in the IMPaCT Back study (ISRCTN 55174281) | 17.2 | 0 | 1 |
| RNA interference: new mechanisms for targeted treatment? | 17.2 | 0 | 1 |
| Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair | 17.2 | 0 | 1 |
| Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership. | 17.2 | 0 | 1 |
| Skin care in the aging female: myths and truths | 17.2 | 0 | 1 |
| Exploring students' perceptions on the use of significant event analysis, as part of a portfolio assessment process in general practice, as a tool for learning how to use reflection in learning. | 17.2 | 0 | 1 |
| Influence of Psoriasis on Household Chores and Time Spent on Skin Care at Home: A Questionnaire Study | 17.2 | 0 | 1 |
| Nonlinear mixed-effects modelling for single cell estimation: when, why, and how to use it | 17.2 | 0 | 1 |
| The wow factor as a determinant of funding for disorders of the skin | 17.2 | 0 | 1 |
| Psychometric Study of the Aberrant Behavior Checklist in Fragile X Syndrome and Implications for Targeted Treatment | 17.2 | 0 | 1 |
| Molecularly targeted treatment for dermatofibrosarcoma protuberans | 17.2 | 0 | 1 |
| When and how to use buccal mucosa grafts in penile and bulbar urethroplasty. | 17.2 | 0 | 1 |
| Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism | 17.2 | 0 | 1 |
| UniProtKB/Swiss-Prot, the Manually Annotated Section of the UniProt KnowledgeBase: How to Use the Entry View | 17.2 | 0 | 1 |
| Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer. | 17.2 | 0 | 1 |
| PDAs in nursing. Here's why & how to use this emerging clinical tool | 17.2 | 0 | 1 |
| A Four-question Approach to Determining the Impact of Acne Treatment on Quality of Life. | 17.2 | 0 | 1 |
| How to use octreotide for malignant bowel obstruction | 17.2 | 0 | 1 |
| How to use the medical subject headings (Me SH ) | 17.2 | 0 | 1 |
| How to use a medical census | 17.2 | 0 | 1 |
| New FDA approvals: how to use them, when to suggest them | 17.2 | 0 | 1 |
| Evaluation of a topical treatment for the relief of sensitive skin. | 17.2 | 0 | 1 |
| Quantification of the DMSO-response--a test for assessment of sensitive skin | 17.2 | 0 | 1 |
| Clinical, biophysical, immunohistochemical, and in vivo reflectance confocal microscopy evaluation of the response of subjects with sensitive skin to home-use fractional non-ablative photothermolysis device. | 17.2 | 0 | 1 |
| Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials. | 17.2 | 0 | 1 |
| Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis | 17.2 | 0 | 1 |
| Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating | 17.2 | 0 | 1 |
| Diapers and skin care: merits and demerits | 17.2 | 0 | 1 |
| Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice. | 17.2 | 0 | 1 |
| The mouse gene expression database: New features and how to use them effectively | 17.2 | 0 | 1 |
| Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer | 17.2 | 0 | 1 |
| Positioning and skin care of the low-birth-weight neonate | 17.2 | 0 | 1 |
| The clinical material of health in paediatrics: Where to Get it, and How to Use it. | 17.2 | 0 | 1 |
| Skin care plan involves more than washing hands. Hygiene strategy counters spread of dermatitis among employees. | 17.2 | 0 | 1 |
| Understanding the anion and osmolal gaps laboratory values: what they are and how to use them | 17.2 | 0 | 1 |
| Replacement and suicide gene therapy for targeted treatment of lung cancer | 17.2 | 0 | 1 |
| Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging | 17.2 | 0 | 1 |
| A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment | 17.2 | 0 | 1 |
| Skin care of the healthy newborn. | 17.2 | 0 | 1 |
| Molecular mechanism of ischemia - Reperfusion injury after myocardial infarction and its possible targeted treatment | 17.2 | 0 | 1 |
| How to use the C-reactive protein in cardiac disease? | 17.2 | 0 | 1 |
| Usage of skin care products and risk of rheumatoid arthritis: results from the Swedish EIRA study | 17.2 | 0 | 1 |
| Why and how to use radioisotopes in human nutrition research. | 17.2 | 0 | 1 |
| Do Early Skin Care Practices Alter the Risk of Atopic Dermatitis? A Case‐Control Study | 17.2 | 0 | 1 |
| From Planar to Cage in 15 Easy Steps: Resolving the C60H21F9(-) → C60(-) Transformation by Ion Mobility Mass Spectrometry. | 17.2 | 0 | 1 |
| How to get published: seven easy steps | 17.2 | 0 | 1 |
| Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma | 17.2 | 0 | 1 |
| How to use central venous pressure measurements | 17.2 | 0 | 1 |
| Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment | 17.2 | 0 | 1 |
| Skin care in the well term newborn: two systematic reviews | 17.2 | 0 | 1 |
| Molecularly targeted treatment of chronic myeloid leukemia: beyond the imatinib era. | 17.2 | 0 | 1 |
| Acne Treatment With 3-Step Broadband Light Protocol | 17.2 | 0 | 1 |
| Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds | 17.2 | 0 | 1 |
| Medical decision-making in membranous nephropathy: how to use limited clinical research evidence in patient management | 17.2 | 0 | 1 |
| Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada | 17.2 | 0 | 1 |
| How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient | 17.2 | 0 | 1 |
| Mexametric and cutometric assessment of the signs of aging of the skin area around the eyes after the use of non-ablative fractional laser, non-ablative radiofrequency and intense pulsed light. | 17.2 | 0 | 1 |
| The therapeutic dilemma: how to use short-acting PDE5 inhibitor drugs | 17.2 | 0 | 1 |
| The therapeutic dilemma: how to use tadalafil | 17.2 | 0 | 1 |
| The therapeutic dilemma: how to use psychotherapy | 17.2 | 0 | 1 |
| The standardization of radiation skin care in British Columbia: a collaborative approach | 17.2 | 0 | 1 |
| How to use and integrate bioinformatics tools to compare proteomic data from distinct conditions? A tutorial using the pathological similarities between Aortic Valve Stenosis and Coronary Artery Disease as a case-study | 17.2 | 0 | 1 |
| The ubiquitin-proteasome system at the crossroads of stress-response and ageing pathways: a handle for skin care? | 17.2 | 0 | 1 |
| Skin care of the healed burned patient | 17.2 | 0 | 1 |
| IVI g TREATMENT OF PEMPHIGUS: how it works and how to use it. | 17.2 | 0 | 1 |
| Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer | 17.2 | 0 | 1 |
| Fermenting Red Ginseng Enhances Its Safety and Efficacy as a Novel Skin Care Anti-Aging Ingredient: In Vitro and Animal Study | 17.2 | 0 | 1 |
| Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey | 17.2 | 0 | 1 |
| When and how to use informatics tools in caring for urologic patients | 17.2 | 0 | 1 |
| Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers | 17.2 | 0 | 1 |
| Adherence to acne treatment guidelines in the military environment - a descriptive, serial cross-sectional study | 17.2 | 0 | 1 |
| Let there be light: how to use photoswitchable cross-linker to reprogram proteins | 17.2 | 0 | 1 |
| In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer | 17.2 | 0 | 1 |
| The importance of skin care and assessment | 17.2 | 0 | 1 |
| Skin care: from skin health to ulcer prevention. | 17.2 | 0 | 1 |
| Adenoviral vectors--how to use them in cancer gene therapy? | 17.2 | 0 | 1 |
| How to use difference plots in quantitative method comparison studies. | 17.2 | 0 | 1 |
| How to assemble a beneficial microbiome in three easy steps | 17.2 | 0 | 1 |
| How to Use t-SNE Effectively | 17.2 | 0 | 1 |
| Tumour stem cell-targeted treatment: elimination or differentiation | 17.2 | 0 | 1 |
| The Sensitive Skin Syndrome | 17.2 | 0 | 1 |
| Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial. | 17.2 | 0 | 1 |
| Enterocutaneous Fistula: Different Surgical Intervention Techniques for Closure along with Comparative Evaluation of Aluminum Paint, Karaya Gum (Hollister) and Gum Acacia for Peristomal Skin Care | 17.2 | 0 | 1 |
| On Bayesian methods of exploring qualitative interactions for targeted treatment. | 17.2 | 0 | 1 |
| Data base management system applications for biocommunicators or how to use a computer to bring order out of chaos | 17.2 | 0 | 1 |
| Neighborhood walkability, fear and risk of falling and response to walking promotion: The Easy Steps to Health 12-month randomized controlled trial | 17.2 | 0 | 1 |
| Why and how to use NSAIDs in osteoarthritis | 17.2 | 0 | 1 |
| Sensory, clinical and physiological factors in sensitive skin: a review | 17.2 | 0 | 1 |
| Concepts in skin care maintenance. | 17.2 | 0 | 1 |
| How to use your dental library | 17.2 | 0 | 1 |
| Some pertinent factors in skin care emulsion | 17.2 | 0 | 1 |
| New developments in acne treatment | 17.2 | 0 | 1 |
| How to use-- and misuse--average length of stay data | 17.2 | 0 | 1 |
| Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options. | 17.2 | 0 | 1 |
| Novel targeted treatment strategies for refractory chronic lymphocytic leukaemia | 17.2 | 0 | 1 |
| Experimental studies on the nature of sensitive skin | 17.2 | 0 | 1 |
| Constructing socio-economic status indices: how to use principal components analysis | 17.2 | 0 | 1 |
| The Lichen-GIS Project, Teaching Students How to Use Bioindicator Species to Assess Environmental Quality | 17.2 | 0 | 1 |
| Molecular pathways in renal cell carcinoma--rationale for targeted treatment | 17.2 | 0 | 1 |
| The National Library of Medicine and how to use it. | 17.2 | 0 | 1 |
| Pediatric skin care: guidelines for assessment, prevention, and treatment. | 17.2 | 0 | 1 |
| A powerful, yet easy to use, computerized analysis of competitive protein binding and radioimmunoassay data | 17.2 | 0 | 1 |
| Prognostic and Predictive Values and Statistical Interactions in the Era of Targeted Treatment | 17.2 | 0 | 1 |
| Do clinicians know how to use pulse oximetry? A literature review and clinical implications. | 17.2 | 0 | 1 |
| Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products | 17.2 | 0 | 1 |
| Comparison of the Efficacy of Atopalm® Multi-Lamellar Emulsion Cream and Physiogel® Intensive Cream in Improving Epidermal Permeability Barrier in Sensitive Skin | 17.2 | 0 | 1 |
| Targeted treatment strategies for menstrual migraine. | 17.2 | 0 | 1 |
| How to use medicines in children: principles of paediatric clinical pharmacology | 17.2 | 0 | 1 |
| Why and how to use insulin therapy earlier in the management of type 2 diabetes | 17.2 | 0 | 1 |
| How to use your library. | 17.2 | 0 | 1 |
| The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival. | 17.2 | 0 | 1 |
| When and how to use tipranavir and darunavir. | 17.2 | 0 | 1 |
| Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography | 17.2 | 0 | 1 |
| Optimal first-line treatment of chronic myeloid leukemia. How to use imatinib and what role for newer drugs? | 17.2 | 0 | 1 |
| Systematic reviews: how they work and how to use them | 17.2 | 0 | 1 |
| How to Use Quality Improvement Tools in Clinical Practice: A Primer for Nephrologists | 17.2 | 0 | 1 |
| A Human Papilloma Virus Testing Algorithm Comprising a Combination of the L1 Broad-Spectrum SPF 10 PCR Assay and a Novel E6 High-Risk Multiplex Type-Specific Genotyping PCR Assay | 17.2 | 0 | 1 |
| Pelvic ultrasonography in anorexia nervosa: what the clinician should ask the radiologist and how to use the information provided | 17.2 | 0 | 1 |
| Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy. | 17.2 | 0 | 1 |
| Tolerance of skin care regimen in healthy, full-term neonates | 17.2 | 0 | 1 |
| Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer | 17.2 | 0 | 1 |
| Users' guides to the medical literature: how to use an article about mortality in a humanitarian emergency | 17.2 | 0 | 1 |
| Users' guide to the surgical literature: how to use an article on economic analysis | 17.2 | 0 | 1 |
| Users' guides to the surgical literature: how to use an article about a diagnostic test. Evidence-Based Surgery Working Group | 17.2 | 0 | 1 |
| How to Use the Candida Genome Database | 17.2 | 0 | 1 |
| A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating an Oral Anti-aging Skin Care Supplement for Treating Photodamaged Skin | 17.2 | 0 | 1 |
| Skin care: an essential component of hand hygiene and infection control | 17.2 | 0 | 1 |
| Peristomal skin care: an overview of available products | 17.2 | 0 | 1 |
| Balancing preterm infants’ developmental needs with parents’ readiness for skin-to-skin care: A phenomenological study | 17.2 | 0 | 1 |
| Reducing signs of aging and increasing lifespan by drug synergy. | 17.2 | 0 | 1 |
| Targeted treatment trials for tuberous sclerosis and autism: no longer a dream | 17.2 | 0 | 1 |
| Current status of antivascular therapy and targeted treatment in the clinic | 17.2 | 0 | 1 |
| Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation | 17.2 | 0 | 1 |
| Choosing a broad-spectrum sunscreen with UVA protection | 17.2 | 0 | 1 |
| Defining the Susceptibility of Acne-Prone and Sensitive Skin Populations to Extrinsic Factors | 17.2 | 0 | 1 |
| The pharmacoeconomics of acne treatment: where are we heading? | 17.2 | 0 | 1 |
| Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics | 17.2 | 0 | 1 |
| Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia | 17.2 | 0 | 1 |
| Skin Cancer in the Crosshairs: Highlights from the Biennial Scientific Retreat of International Transplant Skin Cancer Collaborative and Skin Care in Organ Transplant Recipients Europe | 17.2 | 0 | 1 |
| How to use linear regression and correlation in quantitative method comparison studies. | 17.2 | 0 | 1 |
| Skin care team in the pediatric intensive care unit: a model for excellence. | 17.2 | 0 | 1 |
| Care or harm: exploring essential components in skin care regimens | 17.2 | 0 | 1 |
| Targeted treatment strategies for sustainable worm control in small ruminants. | 17.2 | 0 | 1 |
| Practical considerations in acne treatment and the clinical impact of topical combination therapy | 17.2 | 0 | 1 |
| Targeted treatment for lymphedema and lymphatic metastasis | 17.2 | 0 | 1 |
| Education and empowerment of the nursing assistant: validating their important role in skin care and pressure ulcer prevention, and demonstrating productivity enhancement and cost savings | 17.2 | 0 | 1 |
| How to use an article about a diagnostic test. | 17.2 | 0 | 1 |
| Selling skin care products in your medspa | 17.2 | 0 | 1 |
| Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin | 17.2 | 0 | 1 |
| A rationale for the targeted treatment of oligometastases with radiotherapy | 17.2 | 0 | 1 |
| Male skin care needs | 17.2 | 0 | 1 |
| Effect of the sun on visible clinical signs of aging in Caucasian skin | 17.2 | 0 | 1 |
| Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer | 17.2 | 0 | 1 |
| Self-management interventions to improve skin care for pressure ulcer prevention in people with spinal cord injuries: a systematic review protocol | 17.2 | 0 | 1 |
| How to use a systematic literature review and meta-analysis | 17.2 | 0 | 1 |
| Targeted treatment and new agents in diffuse large B-cell lymphoma | 17.2 | 0 | 1 |
| Skin care of the diaper area | 17.2 | 0 | 1 |
| How to use an article about therapy | 17.2 | 0 | 1 |
| Antioxidants used in skin care formulations. | 17.2 | 0 | 1 |
| Addressing patient variability: clinical challenges in the initiation of acne treatment | 17.2 | 0 | 1 |
| Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers | 17.2 | 0 | 1 |
| Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature | 17.2 | 0 | 1 |
| Targeted treatment in COPD: a multi-system approach for a multi-system disease | 17.2 | 0 | 1 |
| How to use a clinical practice guideline. | 17.2 | 0 | 1 |
| Open-label treatment of moderate or marked melasma with a 4% hydroquinone skin care system plus 0.05% tretinoin cream | 17.2 | 0 | 1 |
| How to use an article about genetic association: A: Background concepts | 17.2 | 0 | 1 |
| How to use an article about genetic association: B: Are the results of the study valid? | 17.2 | 0 | 1 |
| Nanocarriers and nanoparticles for skin care and dermatological treatments | 17.2 | 0 | 1 |
| How to use an article about genetic association: C: What are the results and will they help me in caring for my patients? | 17.2 | 0 | 1 |
| How to use: a pH study. | 17.2 | 0 | 1 |
| How to use virological tools for optimal management of chronic hepatitis C. | 17.2 | 0 | 1 |
| Gentle cleansing and moisturizing for patients with atopic dermatitis and sensitive skin | 17.2 | 0 | 1 |
| Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel | 17.2 | 0 | 1 |
| Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA. | 17.2 | 0 | 1 |
| Teaching medical students how to use interpreters: a three year experience | 17.2 | 0 | 1 |
| Platelet and reticulocyte new parameters: why and how to use them? | 17.2 | 0 | 1 |
| Newer antiretroviral agents and how to use them | 17.2 | 0 | 1 |
| Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment. | 17.2 | 0 | 1 |
| Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients. | 17.2 | 0 | 1 |
| Putative neuronal mechanisms of sensitive skin | 17.2 | 0 | 1 |
| Locoregional and radioisotopic targeted treatment of neuroendocrine tumours | 17.2 | 0 | 1 |
| Acetylene-derived polymers and their applications in hair and skin care | 17.2 | 0 | 1 |
| Molecular targeted treatment and radiation therapy for rectal cancer | 17.2 | 0 | 1 |
| Characterization of heavy users of skin care products among Norwegian women from 2003 to 2011. | 17.2 | 0 | 1 |
| Newer antiretroviral agents and how to use them | 17.2 | 0 | 1 |
| Skin care during the menopause period: noninvasive procedures of beauty studies | 17.2 | 0 | 1 |
| Skin care for preterm and term neonates | 17.2 | 0 | 1 |
| Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug | 17.2 | 0 | 1 |
| Cervical cancer therapy: current, future and anti-angiogensis targeted treatment | 17.2 | 0 | 1 |
| Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide | 17.2 | 0 | 1 |
| Botanicals in skin care products | 17.2 | 0 | 1 |
| Skin care and pressure ulcers | 17.2 | 0 | 1 |
| Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients | 17.2 | 0 | 1 |
| NICU nurses’ ambivalent attitudes in skin-to-skin care practice | 17.2 | 0 | 1 |
| Emotion Regulation Therapy: A Mechanism-Targeted Treatment for Disorders of Distress | 17.2 | 0 | 1 |
| Antigen-based assays for the identification of influenza virus and respiratory syncytial virus: why and how to use them in pediatric practice | 17.2 | 0 | 1 |
| Infant and Young Child Feeding Practices in Infants Receiving Skin to Skin Care at Birth: Follow-up of Randomized Cohort | 17.2 | 0 | 1 |
| Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes. | 17.2 | 0 | 1 |
| Aging gracefully. Skin care for midlife and older women | 17.2 | 0 | 1 |
| HER-2 targeted treatment of osteosarcoma: the challenges of developing targeted therapy and prognostic factors for rare malignancies | 17.2 | 0 | 1 |
| Neonatal skin care: prevention of skin breakdown | 17.2 | 0 | 1 |
| How to Use the American Geriatrics Society 2015 Beers Criteria-A Guide for Patients, Clinicians, Health Systems, and Payors | 17.2 | 0 | 1 |
| Antioxidants and skin care: the essentials | 17.2 | 0 | 1 |
| The effectiveness of a skin care program for the prevention of contact dermatitis in health care workers (the Healthy Hands Project): study protocol for a cluster randomized controlled trial | 17.2 | 0 | 1 |
| Phototherapy for psoriasis: what to choose and how to use: facts and controversies | 17.2 | 0 | 1 |
| Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available | 17.2 | 0 | 1 |
| Active agents in common skin care products | 17.2 | 0 | 1 |
| Isn't it about time we learned how to use blood transfusion in patients with ischemic heart disease? | 17.2 | 0 | 1 |
| Should interventions to treat or prevent Alzheimer’s disease be tested in a population or as targeted treatment of highly selected study participants? | 17.2 | 0 | 1 |
| Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer | 17.2 | 0 | 1 |
| Pathophysiology of NASH: Perspectives for a Targeted Treatment | 17.2 | 0 | 1 |
| Investigating skin-to-skin care patterns with extremely preterm infants in the NICU and their effect on early cognitive and communication performance: a retrospective cohort study | 17.2 | 0 | 1 |
| Targeted treatment and new agents in peripheral T-cell lymphoma | 17.2 | 0 | 1 |
| Cloning in M13 phage or how to use biology at its best | 17.2 | 0 | 1 |
| Targeted treatment and new agents in diffuse large B cell lymphoma | 17.2 | 0 | 1 |
| Sensitive skin: closing in on a physiological cause | 17.2 | 0 | 1 |
| Targeted treatment and new agents in follicular lymphoma | 17.2 | 0 | 1 |
| Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib | 17.2 | 0 | 1 |
| Mitochondria: a new focus as an anti-aging target in skin care | 17.2 | 0 | 1 |
| Targeted treatment for metastatic renal cell carcinoma and immune regulation. | 17.2 | 0 | 1 |
| Interpretations: How to use faecal elastase testing | 17.2 | 0 | 1 |
| How to use acylcarnitine profiles to help diagnose inborn errors of metabolism. | 17.2 | 0 | 1 |
| Somatostatin receptor imaging with (111)In-pentetreotide in gastro-intestinal tract and lung neuroendocrine tumors-Impact on targeted treatment | 17.2 | 0 | 1 |
| From Saccharomyces cerevisiae to Candida glabratain a few easy steps: important adaptations for an opportunistic pathogen | 17.2 | 0 | 1 |
| Biologic activities of molecular chaperones and pharmacologic chaperone imidazole-containing dipeptide-based compounds: natural skin care help and the ultimate challenge: implication for adaptive responses in the skin | 17.2 | 0 | 1 |
| Establishing a profitable skin care practice in a facial plastic surgery office | 17.2 | 0 | 1 |
| Beyond chemotherapy: new agents for targeted treatment of lymphoma | 17.2 | 0 | 1 |
| Targeted treatment of pruritus: a look into the future | 17.2 | 0 | 1 |
| How to use… eye swabs | 17.2 | 0 | 1 |
| State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors | 17.2 | 0 | 1 |
| MR evaluation of response to targeted treatment in cancer cells. | 17.2 | 0 | 1 |
| Viral oncogenesis and its role in nonmelanoma skin cancer | 17.2 | 0 | 1 |
| Children and newborn skin care and prevention | 17.2 | 0 | 1 |
| Sensitive, Specific, Predictive… Statistical Basics: How to Use Biomarkers | 17.2 | 0 | 1 |
| Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases | 17.2 | 0 | 1 |
| Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection | 17.2 | 0 | 1 |
| Peristomal skin care and the use of accessories to promote skin health | 17.2 | 0 | 1 |
| How to use Chlamydia antibody testing in subfertility patients | 17.2 | 0 | 1 |
| Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report | 17.2 | 0 | 1 |
| The use of photosensitisers in acne treatment | 17.2 | 0 | 1 |
| Best face forward: a commonsense guide to acne treatment | 17.2 | 0 | 1 |
| Use of drospirenone/ethinyl estradiol (DRSP/EE) among women with acne reduces acne treatment-related resources. | 17.2 | 0 | 1 |
| Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? | 17.2 | 0 | 1 |
| How to use prognostic factors in axillary node-negative breast cancer patients | 17.2 | 0 | 1 |
| Urine electrolytes and osmolality: when and how to use them | 17.2 | 0 | 1 |
| Approach to pediatric acne treatment: an update | 17.2 | 0 | 1 |
| Radiopharmaceuticals: when and how to use them to treat metastatic bone pain | 17.2 | 0 | 1 |
| The empiric use of palm kernel oil in neonatal skin care: justifiable or not? | 17.2 | 0 | 1 |
| Over-the-counter topical skincare products: a review of the literature. | 17.2 | 0 | 1 |
| Comparison of standardized peristomal skin care and crusting technique in prevention of peristomal skin problems in ostomy patients | 17.2 | 0 | 1 |
| Use of a video-ethnographic intervention (PRECESS Immersion Method) to improve skin-to-skin care and breastfeeding rates. | 17.2 | 0 | 1 |
| How to use interpreters in general practice: the development of a New Zealand toolkit | 17.2 | 0 | 1 |
| Male skin and ingredients relevant to male skin care | 17.2 | 0 | 1 |
| DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment. | 17.2 | 0 | 1 |
| Skin care considerations in the neonate for the ET nurse. | 17.2 | 0 | 1 |
| The placebo in practice: how to use it in clinical routine | 17.2 | 0 | 1 |
| Chemotherapy and molecular‐targeted treatment for unresectable hepatic metastases: a Japanese perspective | 17.2 | 0 | 1 |
| CAD: how it works, how to use it, performance | 17.2 | 0 | 1 |
| Learning from photosynthesis: how to use solar energy to make fuels | 17.2 | 0 | 1 |
| How to use... alkaline phosphatase in neonatology | 17.2 | 0 | 1 |
| How to use near-patient capillary ketone meters. | 17.2 | 0 | 1 |
| How to use toxicology screening tests | 17.2 | 0 | 1 |
| How to Use Apps Clinically in the Treatment of Aphasia | 17.2 | 0 | 1 |
| Sensitive skin: an overview | 17.2 | 0 | 1 |
| How to use... lupus anticoagulants | 17.2 | 0 | 1 |
| Nanocarriers for the targeted treatment of ovarian cancers. | 17.2 | 0 | 1 |
| Adjunctive Skin Care of the Brow and Periorbital Region | 17.2 | 0 | 1 |
| How to use new biology to guide therapy in multiple myeloma. | 17.2 | 0 | 1 |
| Sensitive skin: An overview | 17.2 | 0 | 1 |
| A fresh look at glucocorticoids how to use an old ally more effectively | 17.2 | 0 | 1 |
| Neonatal skin care: a concise review | 17.2 | 0 | 1 |
| Tyrosine Kinase Targeted Treatment of Chronic Myelogenous Leukemia and Other Myeloproliferative Neoplasms | 17.2 | 0 | 1 |
| Skin pH: From Basic SciencE to Basic Skin Care | 17.2 | 0 | 1 |
| Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment. | 17.2 | 0 | 1 |
| Guidelines on the role of skin care in the management of mobile populations. | 17.2 | 0 | 1 |
| Newborn skin care. | 17.2 | 0 | 1 |
| The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer | 17.2 | 0 | 1 |
| How to use... neonatal TORCH testing | 17.2 | 0 | 1 |
| How to use ambulatory blood pressure monitoring in resistant hypertension | 17.2 | 0 | 1 |
| Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring | 17.2 | 0 | 1 |
| Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib | 17.2 | 0 | 1 |
| How to use: interferon γ release assays for tuberculosis | 17.2 | 0 | 1 |
| Review on Targeted Treatment of Patients with Advanced-Stage Renal Cell Carcinoma: A Medical Oncologist's Perspective | 17.2 | 0 | 1 |
| Bridging Science and Clinical Practice: How to Use Molecular Markers When Caring for a Patient with Brain Cancer | 17.2 | 0 | 1 |
| Skin care for infants: an evidence-based review | 17.2 | 0 | 1 |
| Gene Therapy, A Targeted Treatment for Diabetic Nephropathy | 17.2 | 0 | 1 |
| Glioblastoma: From Molecular Pathology to Targeted Treatment | 17.2 | 0 | 1 |
| How to use lactate | 17.2 | 0 | 1 |
| Prophylaxis of Acute Radiation Dermatitis with an Innovative FDA-Approved Two-Step Skin Care System in a Patient with Head and Neck Cancer Undergoing a Platin-Based Radiochemotherapy: A Case Report and Review of the Literature | 17.2 | 0 | 1 |
| How to use...the paediatric ECG. | 17.2 | 0 | 1 |
| Routine skin care as prophylaxis and treatment | 17.2 | 0 | 1 |
| A Lifetime of Well Skin Care: Practical Recommendations for Clinicians and Patients | 17.2 | 0 | 1 |
| How to use molecular testing results to guide surgery: a surgeon's perspective | 17.2 | 0 | 1 |
| Holding up the mirror: how to use quality assurance, peer review to improve sexual health | 17.2 | 0 | 1 |
| Recommendations on negative pressure wound therapy with instillation and antimicrobial solutions - when, where and how to use: what does the evidence show? | 17.2 | 0 | 1 |
| Current and future evidence-based acne treatment: a review. | 17.2 | 0 | 1 |
| The detectability half‐life in arthropod predator–prey research: what it is, why we need it, how to measure it, and how to use it | 17.2 | 0 | 1 |
| Honey in dermatology and skin care: a review | 17.2 | 0 | 1 |
| How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide | 17.2 | 0 | 1 |
| How to use: bacterial cultures in diagnosing lower respiratory tract infections in cystic fibrosis | 17.2 | 0 | 1 |
| How to use… blood cultures | 17.2 | 0 | 1 |
| In vitro techniques to assess the proficiency of skin care cosmetic formulations | 17.2 | 0 | 1 |
| How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications | 17.2 | 0 | 1 |
| How to use a subgroup analysis: users' guide to the medical literature | 17.2 | 0 | 1 |
| The immune system and response to HER2-targeted treatment in breast cancer | 17.2 | 0 | 1 |
| How to use antistreptolysin O titre. | 17.2 | 0 | 1 |
| Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial. | 17.2 | 0 | 1 |
| Are plants used for skin care in South Africa fully explored? | 17.2 | 0 | 1 |
| Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib | 17.2 | 0 | 1 |
| The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products | 17.2 | 0 | 1 |
| Targeted treatment of ovarian cancer--the multiple - kinase - inhibitor sorafenib as a potential option | 17.2 | 0 | 1 |
| Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa | 17.2 | 0 | 1 |
| How to use central venous catheter tip cultures | 17.2 | 0 | 1 |
| The skin health and beauty pyramid: a clinically based guide to selecting topical skincare products | 17.2 | 0 | 1 |
| Recommendations for adjunctive basic skin care in patients with psoriasis | 17.2 | 0 | 1 |
| The concept of a toolbox of outcome measures for children with cerebral palsy: why, what, and how to use? | 17.2 | 0 | 1 |
| Predictive factors to targeted treatment in gastrointestinal carcinomas. | 17.2 | 0 | 1 |
| Targeted treatment for sonic hedgehog-dependent medulloblastoma | 17.2 | 0 | 1 |
| A Delphi Study for the Development of an Infant Skin Breakdown Risk Assessment Tool | 17.2 | 0 | 1 |
| Role in calcineurin inhibitors for inflammatory bowel disease in the biologics era: when and how to use. | 17.2 | 0 | 1 |
| A New Targeted Treatment for Lung Cancer Patients | 17.2 | 0 | 1 |
| How to use: amplitude-integrated EEG (aEEG). | 17.2 | 0 | 1 |
| An Emerging Molecular Understanding and Novel Targeted Treatment Approaches in Pediatric Kidney Diseases | 17.2 | 0 | 1 |
| Current clinical practice in atopic dermatitis | 17.2 | 0 | 1 |
| Urostomy management in the community | 17.2 | 0 | 1 |
| How to use… microarray comparative genomic hybridisation to investigate developmental disorders. | 17.2 | 0 | 1 |
| Radiotherapy-induced skin reactions: prevention and cure | 17.2 | 0 | 1 |
| How to use the erythrocyte sedimentation rate in paediatrics | 17.2 | 0 | 1 |
| A systematic review and meta-analysis of randomized controlled trials comparing interventions for peristomal skin care | 17.2 | 0 | 1 |
| What is sensitive skin? A systematic literature review of objective measurements. | 17.2 | 0 | 1 |
| Current and future intratumoral targeted treatment for pancreatic cancer. | 17.2 | 0 | 1 |
| Developing a Wound and Skin Care Program | 17.2 | 0 | 1 |
| How to use: the direct antiglobulin test in newborns | 17.2 | 0 | 1 |
| Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems | 17.2 | 0 | 1 |
| Facial skin care products and cosmetics | 17.2 | 0 | 1 |
| How to use: nutritional assessment in children. | 17.2 | 0 | 1 |
| Evidence‐Based Practice for Intrapartum Care: The Pearls of Midwifery | 17.2 | 0 | 1 |
| Wikidata:How to use data on Wikimedia projects | 17.2 | 0 | 1 |
| Cerebral oxygenation during skin-to-skin care in preterm infants not receiving respiratory support | 17.2 | 0 | 1 |
| Alcoholic liver disease: mechanisms of injury and targeted treatment | 17.2 | 0 | 1 |
| Frequency of Primary Nonadherence to Acne Treatment | 17.2 | 0 | 1 |
| Lifting the veil: how to use clinical neuropsychology to assess dementia | 17.2 | 0 | 1 |
| A practical approach to evidence-based dentistry: VI: How to use a systematic review | 17.2 | 0 | 1 |
| Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment | 17.2 | 0 | 1 |
| Safe Sleep and Skin-to-Skin Care in the Neonatal Period for Healthy Term Newborns | 17.2 | 0 | 1 |
| Daylight photodynamic therapy with 1.5% 3-butenyl 5-aminolevulinate gel as a convenient, effective and safe therapy in acne treatment: A double-blind randomized controlled trial | 17.2 | 0 | 1 |
| Newborn infant skin: Physiology, development, and care | 17.2 | 0 | 1 |
| The Role of CD44 in Disease Pathophysiology and Targeted Treatment. | 17.2 | 0 | 1 |
| When and how to use BRS in bifurcations? | 17.2 | 0 | 1 |
| The perception threshold measurement can be a useful tool for evaluation of sensitive skin | 17.2 | 0 | 1 |
| Skin care in the space environment | 17.2 | 0 | 1 |
| Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy | 17.2 | 0 | 1 |
| Users' guide to the surgical literature: how to use a decision analysis. | 17.2 | 0 | 1 |
| How to use… lumbar puncture in children | 17.2 | 0 | 1 |
| A programme to reduce acquired pressure ulcers in care homes | 17.2 | 0 | 1 |
| Implementing Skin-to-Skin Care in the Operating Room After Cesarean Birth | 17.2 | 0 | 1 |
| Lack of Agreement on How to Use Antegrade Enemas in Children | 17.2 | 0 | 1 |
| Advanced Skin Care – A Novel Ingredient | 17.2 | 0 | 1 |
| How to use the medical literature for fun and profit. | 17.2 | 0 | 1 |
| From novel insights in molecular biology to targeted treatment approaches in head and neck cancer | 17.2 | 0 | 1 |
| Pathogenesis and targeted treatment of skin injury in SLE | 17.2 | 0 | 1 |
| How to use vancomycin optimally in neonates: remaining questions | 17.2 | 0 | 1 |
| Baby powder use in infant skin care. Parental knowledge and determinants of powder usage | 17.2 | 0 | 1 |
| Principles of skin care in the elderly | 17.2 | 0 | 1 |
| Voriconazole: How to Use This Antifungal Agent and What to Expect | 17.2 | 0 | 1 |
| How to Use Research Findings in Your Practice NOW | 17.2 | 0 | 1 |
| Cohesive Polydensified Matrix Hyaluronic Acid for Fine Lines | 17.2 | 0 | 1 |
| Brief analysis of causes of sensitive skin and advances in evaluation of anti‐allergic activity of cosmetic products | 17.2 | 0 | 1 |
| How to use D-dimer in acute cardiovascular care | 17.2 | 0 | 1 |
| Social Media: How to Use It Effectively | 17.2 | 0 | 1 |
| Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita. | 17.2 | 0 | 1 |
| Simple Analysis of Deposited Gene Expression Datasets for the Non-Bioinformatician: How to Use GEO for Fibrosis Research | 17.2 | 0 | 1 |
| Easy to use and reliable technique for online dissolved oxygen tension measurement in shake flasks using infrared fluorescent oxygen-sensitive nanoparticles. | 17.2 | 0 | 1 |
| Pathoanatomic Risk Factors for Instability and Adjacent Segment Disease in Lumbar Spine: How to Use Topping Off? | 17.2 | 0 | 1 |
| Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients | 17.2 | 0 | 1 |
| Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia | 17.2 | 0 | 1 |
| Acne treatment in antiquity: can approaches from the past be relevant in the future? | 17.2 | 0 | 1 |
| The effect of targeted treatment on people with patellofemoral pain: a pragmatic, randomised controlled feasibility study | 17.2 | 0 | 1 |
| Targeted treatment in severe traumatic brain injury in the age of precision medicine. | 17.2 | 0 | 1 |
| Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma. | 17.2 | 0 | 1 |
| Is Twice-Daily Skin Moisturizing More Effective Than Routine Care in the Prevention of Skin Tears in the Elderly Population? | 17.2 | 0 | 1 |
| The Compatibility of Chlorhexidine and a Skin Care Product Line: A Real-World Analysis of Hospital-Acquired Infection Rates | 17.2 | 0 | 1 |
| Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use? | 17.2 | 0 | 1 |
| What Does It Take for an Infant to Learn How to Use a Tool by Observation? | 17.2 | 0 | 1 |
| Prediction of Response to Targeted Treatment in Rheumatoid Arthritis | 17.2 | 0 | 1 |
| Inflammatory Acne Treatment: Review of Current and New Topical Therapeutic Options | 17.2 | 0 | 1 |
| Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas | 17.2 | 0 | 1 |
| How to become a Bayesian in eight easy steps: An annotated reading list. | 17.2 | 0 | 1 |
| Sensitive skin. | 17.2 | 0 | 1 |
| Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform | 17.2 | 0 | 1 |
| Annexin-directed β-glucuronidase for the targeted treatment of solid tumors | 17.2 | 0 | 1 |
| Design and synthesis of phosphoryl-substituted diphenylpyrimidines (Pho-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors: Targeted treatment of B lymphoblastic leukemia cell lines | 17.2 | 0 | 1 |
| STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer | 17.2 | 0 | 1 |
| Tendency to irritation: sensitive skin | 17.2 | 0 | 1 |
| When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH | 17.2 | 0 | 1 |
| New Horizons for Targeted Treatment of Neuroendocrine Tumors | 17.2 | 0 | 1 |
| Recommendations from a European Roundtable Meeting on Best Practice Healthy Infant Skin Care | 17.2 | 0 | 1 |
| Improving Cancer Care Through the Patient Experience: How to Use Patient-Reported Outcomes in Clinical Practice | 17.2 | 0 | 1 |
| Polymeric micellar nanocarriers of benzoyl peroxide as potential follicular targeting approach for acne treatment | 17.2 | 0 | 1 |
| Neuropsychiatric factors in sensitive skin | 17.2 | 0 | 1 |
| How to Use a Randomized Clinical Trial Addressing a Surgical Procedure: Users' Guide to the Medical Literature | 17.2 | 0 | 1 |